FPH vs CCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

FPH

38.5
AI Score
VS
FPH Wins

CCS

37.8
AI Score

Investment Advisor Scores

FPH

39score
Recommendation
AVOID NEW MONEY

CCS

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FPH CCS Winner
Forward P/E 11.2994 18.6567 FPH
PEG Ratio 0 0.45 Tie
Revenue Growth 8.4% -11.8% FPH
Earnings Growth 228.2% -64.8% FPH
Tradestie Score 38.5/100 37.8/100 FPH
Profit Margin 24.9% 2.9% FPH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

FPH 1M: -0.5% · 3M: -15.4% CCS 1M: -1.7% · 3M: -23.2%

Current Technical Phase

FPH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $4.38

CCS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $54.09

Fundamentals Snapshot

Metric FPH CCS
Market Cap — —
Forward P/E 11.3 23.4
Trailing P/E 11.4 15.2
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.5% 0.2%
Operating Margin -0.3% 0.0%
EPS 0.39 3.75
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, FPH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.